RNAC · Cartesian Therapeutics, Inc.
$10.23
-0.26 (-2.48%)
At close · Aug 20
Market Cap
$312.24M
Shares
30.26M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-12-13 | — | $100,000,000 | — | — | 10-K , filed 2026-03-09 |
Key facts
CIK
1453687
CUSIP
816212302
13F (30d)
92 filings
90 filers
Visit website
Investor relations